- Main /
- Company /
- 657-paige-ai

Paige.Ai
Platform or rapid diagnostic
Company websiteFoundation year
2017
Pre-IPO
Current offer
Placement price Available after authorization
Minimum investment Available after authorization
Available volume Available after authorization
About
Developer of a computational pathology module platform aimed at swift diagnostic stratification and cancer detection. The platform utilizes deep learning algorithms based on convolutional and recurrent neural networks, as well as generative models, focusing on breast, prostate, and other major cancer types. This allows clinical researchers and pathologists to understand disease progression with various mutations for more effective treatment.
Investors
Healthcare Venture Partners,
Palkon Capital Management,
Casdin Capital Venture Capital,
Catalio Capital Management,
Johnson & Johnson Innovation